首页> 外文期刊>The pharmaceutical journal >PrEP back on agenda for NHS England
【24h】

PrEP back on agenda for NHS England

机译:PrEP重返英国NHS议程

获取原文
获取原文并翻译 | 示例
           

摘要

In March 2016, NHS England removed HIV prevention drug pre-exposure prophylaxis (PrEP) from its commissioning process - just months before it was due to conclude. After looking at NHS England's decision, the National AIDS Trust was certain we had a legal basis to challenge this. We started those proceedings on 12 April 2016. By 18 April, NHS England responded, saying it would reconsider its decision. If it all goes well, this means PrEP could be back on the cards.
机译:2016年3月,英国NHS取消了HIV预防药物暴露前预防(PrEP)的调试过程-即将结束的几个月。在查看了NHS England的决定后,国家艾滋病基金会(National AIDS Trust)确信我们有法律依据对此提出质疑。我们于2016年4月12日启动了这些程序。4月18日,英格兰NHS做出回应,称它将重新考虑其决定。如果一切顺利,这意味着PrEP可能会恢复正常。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号